Market Overview

UPDATE: Morgan Stanley Initiates Coverage On Intuitive Surgical

Share:
Related ISRG
Greenlight Capital's Q2 Investor Letter: Brexit, Central Bank's 'Failing Policies,' Top Stock Picks And More
Following Intuitive Surgical's Solid Q2, Citi Asks What's Next
Sam Isaly Swaps ' Health Care Stocks in Second Quarter (GuruFocus)

In a report released Wednesday, Morgan Stanley analyst David Lewis initiated coverage on Intuitive Surgical (NASDAQ: ISRG) with a base case of $370. Morgan Stanley previously had an Overweight rating.

Analysts at Morgan Stanley believe Intuitive Surgical's improved procedures will result in a short run investor relief rally, but they don't see proof of inflection. Lewis claimed Intuitive Surgical's ability to manage stock-comp is out of range compared to its peers.

Morgan Stanley is prevented from calling an inflection due to system utilization rates continuing to be in negative territory year-over-year. This indicates underlying demand for new systems, comps uncertainty from its recovery to decline and net system payments decline quarter-over-quarter.

Morgan Stanley's base case of $370 per share was given by a 25x multiple from its 2015 estimate of $14.78.

Latest Ratings for ISRG

DateFirmActionFromTo
Jul 2016BarclaysMaintainsOverweight
Jul 2016CitigroupMaintainsBuy
Jun 2016Goldman SachsDowngradesBuyNeutral

View More Analyst Ratings for ISRG
View the Latest Analyst Ratings

Posted-In: David Lewis Morgan StanleyAnalyst Color Initiation Analyst Ratings

 

Related Articles (ISRG)

View Comments and Join the Discussion!